Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria

09 Jul 20264 min read0 viewsJournal Feed

GIST (Key Takeaways)

The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches. Reich, D. S., Lucchinetti, C.
F. & Calabresi, P. A. N.
Engl. J. Med. 378 , 169–180 (2018).
This research was supported in part by the Intramural Research Program of the US National Institutes of Health (NIH). The contributions of the NIH authors are considered works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services. Division of Neurology, Department of Medicine, St.